Literature DB >> 28515500

Comment on "Probable Tapentadol-Associated Serotonin Syndrome After Overdose".

Marc Russo, Danielle Santarelli, Geoff Isbister.   

Abstract

Entities:  

Year:  2017        PMID： 28515500      PMCID： PMC5424825          DOI： 10.1310/hpj5204-248

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN： 0018-5787


× No keyword cloud information.
  7 in total

1.  The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.

Authors:  E J C Dunkley; G K Isbister; D Sibbritt; A H Dawson; I M Whyte
Journal:  QJM       Date:  2003-09

2.  Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely.

Authors:  Nicole M Ryan; Geoffrey K Isbister
Journal:  Clin Toxicol (Phila)       Date:  2015-04-22       Impact factor: 4.467

3.  Serotonin syndrome.

Authors:  Nicholas A Buckley; Andrew H Dawson; Geoffrey K Isbister
Journal:  BMJ       Date:  2014-02-19

4.  Therapeutics in clinical toxicology: in the absence of strong evidence how do we choose between antidotes, supportive care and masterful inactivity.

Authors:  Geoffrey K Isbister; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2016-03       Impact factor: 4.335

5.  Probable Tapentadol-Associated Serotonin Syndrome After Overdose.

Authors:  Heather Walczyk; Cheuk H Michael Liu; Antonia Alafris; Henry Cohen
Journal:  Hosp Pharm       Date:  2016-04

Review 6.  Management of opioid analgesic overdose.

Authors:  Edward W Boyer
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

Review 7.  Mechanistic and functional differentiation of tapentadol and tramadol.

Authors:  Robert B Raffa; Helmut Buschmann; Thomas Christoph; Gary Eichenbaum; Werner Englberger; Christopher M Flores; Torsten Hertrampf; Babette Kögel; Klaus Schiene; Wolfgang Straßburger; Rolf Terlinden; Thomas M Tzschentke
Journal:  Expert Opin Pharmacother       Date:  2012-06-15       Impact factor: 3.889
  7 in total
  1 in total

Review 1.  Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic.

Authors:  Ariane Stollenwerk; Melanie Sohns; Fabian Heisig; Christian Elling; Detlef von Zabern
Journal:  Adv Ther       Date:  2017-12-21       Impact factor: 3.845
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.